(Q33950294)

30 July 2017

1 reference

title

Eicosanoids and the large intestine (English)

1 reference

30 July 2017

Krause W

1

1 reference

PubMed ID

10867126

30 July 2017

DuBois RN

series ordinal

2

1 reference

30 July 2017

1 May 2000

1 reference

Prostaglandins and Other Lipid Mediators

30 July 2017

1 reference

30 July 2017

61

1 reference

30 July 2017

3-4

1 reference

30 July 2017

145-161

1 reference

Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Distribution of prostaglandin E receptors in the rat gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Cellular distribution of prostanoid EP receptors mRNA in the rat gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Patterns of prostaglandin synthesis and degradation in isolated superficial and proliferative colonic epithelial cells compared to residual colon

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Synthesis and degradation of prostaglandin E2 in the epithelial and sub-epithelial layers of the rat intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Prostaglandin profile and synthetic capacity of the colon: comparison of tissue sources and subcellular fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Effect of prostaglandin on ion transport across isolated colonic mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Apical membrane chloride channels in a colonic cell line activated by secretory agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Chloride secretory mechanism induced by prostaglandin E1 in a colonic epithelial cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Differential effects of inflammatory mediators on ion secretion in the guinea-pig colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Stimulation of colonic secretion by lipoxygenase metabolites of arachidonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Role of prostaglandins and calcium in the effects of Entamoeba histolytica on colonic electrolyte transport

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Significance of calcium for the prostaglandin E2-mediated secretory response to 5-hydroxytryptamine in the small intestine of the rat in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Interleukins 1 and 3 stimulate anion secretion in chicken intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Phorbol ester-stimulated secretion in chicken ileum: role of arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

IL-1beta and TNF-alpha, but not IFN-alpha, IFN-gamma, IL-6 or IL-8, are secretory mediators in human distal colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Platelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Hydrogen peroxide stimulates rat colonic prostaglandin production and alters electrolyte transport

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Thromboxane A2, released by the anti-tumour drug irinotecan, is a novel stimulator of Cl- secretion in isolated rat colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Tumour necrosis factor alpha changes porcine intestinal ion transport through a paracrine mechanism involving prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Effects of bradykinin on the canine proximal colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

TGF-alpha reduces bradykinin-stimulated ion transport and prostaglandin release in human colonic epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

The effect of intravenous prostaglandin F2 alpha and E2 on the motility of the sigmoid colon

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Changes in colonic motility induced by sennosides in dogs: evidence of a prostaglandin mediation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Effects of prostaglandins E2 and F2 alpha on electromyogram of cat colon in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Inhibition of spontaneous smooth muscle contractions in rat and rabbit intestine by blockers of the thromboxane A2 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Inflammatory bowel disease (2)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Inflammatory bowel disease (1)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Eicosanoids and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Leukotriene synthesis by human gastrointestinal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Eicosanoids and inflammatory bowel disease: regulation and prospects for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Inter-relationships between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Studies of prostaglandins and sulphasalazine in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Diclofenac delays healing of gastroduodenal mucosal lesions. Double-blind, placebo-controlled endoscopic study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Lack of beneficial effect of COX-2 inhibitors in an experimental model of colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Effects of a thromboxane A2 receptor antagonist in an animal model of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Eicosanoids and the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Sulindac for polyposis of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Thromboxane A2, prostaglandins, and mesangial cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Effects of eicosanoid metabolism inhibitors on growth of a human gastric tumour cell line (HGT).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Prostaglandin E2 and rat liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Eicosanoids derived from arachidonic and eicosapentaenoic acids inhibit T cell proliferative response

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Regulation of astrocyte proliferation by prostaglandin E2 and the alpha subtype of protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

E2 prostaglandins modulate cell proliferation in the small intestinal epithelium of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Indomethacin inhibits cell proliferation in the oxyntic epithelium of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Prostaglandin E2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

ApcMin: A mouse model for intestinal and mammary tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Elevated cyclooxygenase-2 levels in Min mouse adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

ONCOGENESIS: Landscaping the Cancer Terrain

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Sulindac inhibits activation of the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Meloxicam inhibits the growth of colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900069-1

7 January 2021

10.1016/S0090-6980(00)00069-1

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10867126